Equitable Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.76M | Sell |
4,866
-814
| -14% | -$279K | 0.07% | 181 |
|
|
2026
Q1 | $2M | Buy |
5,680
+365
| +7% | +$130K | 0.09% | 156 |
|
|
2025
Q4 | $1.74M | Sell |
5,315
-158
| -3% | -$50.1K | 0.08% | 169 |
|
|
2025
Q3 | $1.54M | Buy |
5,473
+482
| +10% | +$140K | 0.07% | 174 |
|
|
2025
Q2 | $1.39M | Buy |
4,991
+150
| +3% | +$42.5K | 0.07% | 189 |
|
|
2025
Q1 | $1.51M | Buy |
4,841
+44
| +0.9% | +$13K | 0.08% | 175 |
|
|
2024
Q4 | $1.25M | Sell |
4,797
-15,984
| -77% | -$4.74M | 0.07% | 190 |
|
|
2024
Q3 | $6.7M | Sell |
20,781
-489
| -2% | -$160K | 0.43% | 45 |
|
|
2024
Q2 | $6.65M | Buy |
21,270
+2,197
| +12% | +$645K | 0.46% | 45 |
|
|
2024
Q1 | $5.42M | Buy |
19,073
+6,900
| +57% | +$2.02M | 0.38% | 59 |
|
|
2023
Q4 | $3.51M | Buy |
12,173
+10,064
| +477% | +$2.74M | 0.26% | 74 |
|
|
2023
Q3 | $567K | Buy |
2,109
+73
| +4% | +$18.2K | 0.05% | 242 |
|
|
2023
Q2 | $452K | Hold |
2,036
| – | – | 0.03% | 274 |
|
|
2023
Q1 | $492K | Sell |
2,036
-116
| -5% | -$28.5K | 0.04% | 253 |
|
|
2022
Q4 | $565K | Buy |
2,152
+239
| +12% | +$64.1K | 0.04% | 244 |
|
|
2022
Q3 | $431K | Hold |
1,913
| – | – | 0.04% | 271 |
|
|
2022
Q2 | $465K | Buy |
1,913
+111
| +6% | +$27.2K | 0.03% | 263 |
|
|
2022
Q1 | $436K | Sell |
1,802
-12
| -0.7% | -$2.76K | 0.03% | 271 |
|
|
2021
Q4 | $408K | Buy |
1,814
+4
| +0.2% | +$844 | 0.03% | 283 |
|
|
2021
Q3 | $385K | Sell |
1,810
-4,543
| -72% | -$1.05M | 0.02% | 264 |
|
|
2021
Q2 | $1.55M | Sell |
6,353
-411
| -6% | -$101K | 0.1% | 152 |
|
|
2021
Q1 | $1.68M | Buy |
6,764
+538
| +9% | +$128K | 0.13% | 140 |
|
|
2020
Q4 | $1.43M | Buy |
6,226
+343
| +6% | +$79.1K | 0.11% | 150 |
|
|
2020
Q3 | $1.5M | Buy |
5,883
+24
| +0.4% | +$5.95K | 0.13% | 135 |
|
|
2020
Q2 | $1.38M | Hold |
5,859
| – | – | 0.13% | 135 |
|
|
2020
Q1 | $1.19M | Buy |
5,859
+3,799
| +184% | +$830K | 0.13% | 135 |
|
|
2019
Q4 | $497K | Buy |
2,060
+132
| +7% | +$29.1K | 0.05% | 202 |
|
|
2019
Q3 | $373K | Buy |
1,928
+247
| +15% | +$47.4K | 0.04% | 213 |
|
|
2019
Q2 | $309K | Sell |
1,681
-129
| -7% | -$23.1K | 0.03% | 238 |
|
|
2019
Q1 | $343K | Buy |
1,810
+406
| +29% | +$77.5K | 0.04% | 224 |
|
|
2018
Q4 | $274K | Sell |
1,404
-41
| -3% | -$8K | 0.04% | 233 |
|
|
2018
Q3 | $299K | Sell |
1,445
-2,235
| -61% | -$440K | 0.03% | 247 |
|
|
2018
Q2 | $680K | Buy |
+3,680
| New | +$651K | 0.09% | 167 |
|
Other funds holding AMGN
Equitable Trust's AMGN Position: Q2 2026 in Review
Equitable Trust reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $279K and leaving 4,866 shares worth $1.76M. The position accounts for 0.07% of the portfolio, ranked #181.
Equitable Trust first reported a position in AMGN in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.7M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Equitable Trust held 4,866 shares of Amgen worth $1.76M as of Q2 2026.
- Equitable Trust sold 814 Amgen shares in Q2 2026, an estimated $279K.
- Amgen made up 0.07% of Equitable Trust's portfolio in Q2 2026, its #181 holding.
- Equitable Trust first reported a position in Amgen in Q2 2018 and has held it in 33 quarters since.
- Equitable Trust's Amgen position peaked at $6.7M in Q3 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.